CRO

Researcher in lab
#Clinical trial #CRO

CRO Pharmagene announces re-launch and lab acquisition 

CRO Pharmagene Discovery Services has announced its re-launch, coinciding with its purchase of a human tissue laboratory business.  Pharmagene, originally founded in 1996, has acquired a business near Cambridge, UK. The company says the business is specialised in the performance of laboratory-based research services using consented human tissue across both preclinical and… Read More

#News

Female researcher in a laboratory
#CRO #Drug development #Drug discovery #Translational chemistry

Integrating translational and clinical research to advance drug development

Dr Kenneth Barr, Head of Strategic Collaborations at Syngene, explores how early-phase drug development is moving towards integrated translational strategies.   Drug development continues to grow in complexity, risk, and cost. With timelines stretching over a decade and the average spend per new drug exceeding $2.6 billion, many… Read More

#Exclusive Content

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Latest Guide: Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this new guide from SGS… Read More

#News

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this SGS guide to discover: How to collaborate… Read More

#Intelligence #Resources

Protein degradation
#Biology #CRO #Drug development #Drug discovery #Genomics #Protein chemistry / Proteomics #Therapeutics

New podcast on CROs and targeted protein degradation

This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence… Read More

#News

#Clinical trials #CRO

Celerion takes industry award for seventh year running  

Clinical research organisation (CRO) Celerion has been recognised for its contributions to the industry by claiming an award for the seventh consecutive year.   The company was named  recipient of the Life Science Leader and Clinical Leader’s CRO Leadership Awards in all five award categories. The awards recognise… Read More

#News

#Clinical trials #CRO #Emmes

Getting the right CRO team: culture is as important as skill set  

The CRO market has seen tremendous growth in the last 10 years, undergoing significant changes in terms of remote trials, smaller patient populations, as well as the more recent pandemic pressures.   The drug pipeline is also now larger than ever and CROs have increased their strategic importance… Read More

#News

#Cellomatics Biosciences #CRO

Cellomatics targets strategic growth with key hire  

Contract research organisation (CRO) Cellomatics Biosciences has appointed a new senior director to help it expand. The company has hired Anand Krishna as senior director to help oversee customer care and management, sales, operations, and marketing. Krishna has over 25 years of executive leadership and field sales management experience… Read More

#News

#Clinical trials #CRO #Whitepaper

Whitepaper: How to reduce your clinical study budget by 55%

Learn how to reduce your clinical study budget by 45-55% in Central and Eastern Europe by downloading this Whitepaper by Research Professionals CRO. This whitepaper identifies the most significant cost elements of a typical clinical study budget and breaks it… Read More

#News

#CRO #Drug development #Drug discovery #Genomics

CROs: Drug discovery expertise on hand  

Listen to this article on the DDW Podcast: Lu Rahman asks Laura Hinton, Operations Director at Gentronix, to offer some insight into the contract research organisation (CRO) market and how Gentronix is making its presence known in this sector.  Gentronix is a specialist contract research organisation (CRO) based in the UK, focused on delivering… Read More

#Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Assay #CRO #Funding #Technology

Gentronix set to double in size following £700k investment 

Gentronix, a UK-based contract research organisation (CRO) working in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.  The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue transgenic mutation… Read More

#News

#Clinical trials #CRO #Pharmaceuticals #Research

Advantages of working with CROs in Central and Eastern Europe 

Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO in this interview with Research Professionals’ Managing Partner, György Barta (DPharm).  Barta discusses the many benefits of conducting clinical studies in CEE as… Read More

#News

#CRO #Data #Drug development

CatSci partners with Cambridge Crystallographic Data Centre 

Medicine developer CatSci has collaborated with the Cambridge Crystallographic Data Centre (CCDC). CatSci’s experimental expertise in material science combined with CCDC’s informatics tools will offer an integrated solution to customers, adding strategic value from molecule to medicine.  CCDC’s informatics-based services apply big data learnings from over one million published crystal structures to better… Read More

#News

#Biosciences #CRO #Drug development #Immuno-oncology #Oncology

High demand for preclinical expertise fuels growth for Nottingham CRO 

Nottingham, UK-based contract research organisation (CRO) Cellomatics Biosciences has reported year-on-year organic revenue growth of 30% since its inception in 2015, as demand for its preclinical and early discovery phase laboratory services and expertise continues to increase.   Based at BioCity Nottingham, Cellomatics is a specialist preclinical CRO with expertise in five main therapeutic areas: oncology,… Read More

#News